Published in Dialogue & Discourse

·Pinned

This Week In The Economy: FDA Expands COVID Booster Shot Eligibility, House Passes BBB, US Consumers Splurge, Fed Governor Calls For Faster Stimulus Withdrawal

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

FDA Expand Booster Eligibility, Pfizer Seeks Emergency Approval of COVID-19 Antiviral Drug

The U.S. Food and Drug Administration this week expanded the eligibility criteria to receive a COVID-19 vaccine booster shot.

The agency has now authorized a single booster dose for all individuals 18 years of age and older who have been fully vaccinated previously with any FDA-authorized or approved COVID-19 vaccine.

…

This Week In The Economy: Booster Shots For Elderly, At-Risk Americans, Fed Divided Over Future Interest Rate Policy, German Manufacturing’s Bottleneck Recession, Diverging Global Monetary Policy

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

US CDC, FDA Authorize Pfizer Vaccine Booster Shots For Elderly, At-Risk Populations

The U.S. Food and Drug Administration this week amended its emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to allow for a single booster dose, to be administered at least six months after completion of the primary series in:

individuals 65 years of age and older;
individuals 18 through 64…

This Week In The Economy: Spike In COVID-19 Cases Continues, US Home Sales Slow Down To End 2021

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

Surge In COVID-19 Cases Continues

Globally, there have now been 334,101,607 confirmed cases of COVID-19, and the number of people killed by the coronavirus rose to 5,554,786. The U.S. now has 69,305,598 confirmed cases, and there have been 860,316 fatalities.

This Week In The Economy: White House To Provide Free COVID Tests, China Price Inflation Slows, Record US Consumer Prices, Economy Feeling Effects Of Omicron/Inflation

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

White House Announces New Measures In Battle Against Omicron Variant

U.S. President Joe Biden this week announced new steps in his administration’s efforts to halt the spread of the highly transmissible COVID-19 variant, Omicron.

The president noted the “millions of cases and record hospitalizations” caused by the coronavirus mutation, and especially the impact on the unvaccinated.

Starting next week, the…

This Week In The Economy: mRNA Over JnJ, Over 800k American Fatalities, Fed Rate Hikes Coming In 2022, Central Banks Dial Back Monetary Support (Except Turkey)

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

CDC Endorses mRNA Vaccine Over J&J, Over 800K U.S. Fatalities

The U.S. Centers for Disease Control this week recommended getting the vaccines manufactured by Pfizer or Moderna, over the single-shot dose made by Johnson & Johnson.

In its statement, the CDC endorsed updated recommendations made by its Advisory Committee on Immunization Practices (ACIP) for the prevention of COVID-19, “expressing a…

This Week In The Economy: Pfizer Booster Vs Omicron, FDA Expands Booster Eligibility, China Producer Prices, Record US Consumer Inflation, Job Openings Vs Hiring, Dour German Outlook

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

Pfizer Says Booster Shot Can Neutralize Omicron

Following last week’s announcement by South African authorities of the discovery of a potentially more contagious COVID-19 mutation — Omicron — there might be good news on the protection front.

Pharmaceutical company Pfizer this week announced results from an initial study that showed antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine…

This Week In The Economy: Omicron, Breaking Down The November US Jobs Report, China Manufacturing Activity Rebounds, EU Inflation Surges

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

Omicron Dominates The News Cycle

There is a new COVID-19 variant on the streets, and its name is Omicron.

First detected by scientists in South Africa, cases with this potentially more contagious mutation have now been seen in Asia, in Europe, and in the United States.

The World Health Organization has classified Omicron as a…

This Week In The Economy: Merck COVID Drug Approved, Big News From Pfizer, Beyond The Headlines of US Jobs Report, Global Food Prices Spike, Fed Not Ready To Raise Rates

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

COVID-19 Antiviral Drug Approved In UK, Global Death Toll Crosses 5 Million Mark

The United Kingdom’s Medicines and Health products Regulatory Agency this week greenlit the use of Merck’s Lagevrio (molnupiravir) antiviral drug in the country, making it the first COVID-19 oral antiviral to be approved anywhere in the world.

The pill “is safe and effective at reducing the risk of hospitalisation and…

This Week In The Economy: More COVID At Home Tests Approved, Build Back Better Outlines Published, Optimistic US Spending Outlook, Diverging Central Bank Policies

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

FDA Approves More COVID At-Home Tests, Merck Licenses Anti-viral Drug

The U.S. Food and Drug Administration this week authorized the 10th and 11th over-the-counter COVID-19 test, and reissued the emergency use authorization for another OTC COVID-19 test.

The FDA Issued an EUA for the Celltrion DiaTrust COVID-19 Ag Home Test, an OTC COVID-19 diagnostic antigen test. The test can be…

This Week In The Economy: Vaccine ‘Mix And Match’ Approved, Another Debt Limit Warning, Supply Chains Disruptions Dampening Activity

Welcome to a regular snapshot-review of U.S. and international economic news that aims to 1) provide a window into the challenges and decisions facing businesses today, 2) determine the direction of economic policy — such as the speed at which central banks decide to raise interest rates, and 3) assess what the impact will be for consumers.

Moderna, J&J COVID-19 Vaccine Boosters Approved, Prep Begins For Vaccinating Kids

The U.S. Food and Drug Administration advisory panel this week announced it is approving booster shots of Moderna and Johnson & Johnson’s COVID-19 vaccines.

The FDA amended the emergency use authorizations for Moderna’s vaccine to allow a single booster administered at least six months after the initial two jabs for…

FDA Expand Booster Eligibility, Pfizer Seeks Emergency Approval of COVID-19 Antiviral Drug

US CDC, FDA Authorize Pfizer Vaccine Booster Shots For Elderly, At-Risk Populations

Surge In COVID-19 Cases Continues

White House Announces New Measures In Battle Against Omicron Variant

CDC Endorses mRNA Vaccine Over J&J, Over 800K U.S. Fatalities

Pfizer Says Booster Shot Can Neutralize Omicron

Omicron Dominates The News Cycle

COVID-19 Antiviral Drug Approved In UK, Global Death Toll Crosses 5 Million Mark

FDA Approves More COVID At-Home Tests, Merck Licenses Anti-viral Drug

Moderna, J&J COVID-19 Vaccine Boosters Approved, Prep Begins For Vaccinating Kids

Brai Odion-Esene